CEL-SCI Corporation logo
CEL-SCI Corporation CVM
$ 1.72 2.38%
report update icon

Quarterly report 2026-Q2
added 05-15-2026

CEL-SCI Corporation Gross Profit | CVM

Gross profit is a key indicator of how efficiently a company produces or sells its products. This metric helps assess a business’s ability to generate revenue at the initial stage, before accounting for all other expenses. Regular analysis of gross profit allows companies to respond in a timely manner to changes in cost of goods, pricing strategy, and market conditions.

Calculation formula:
Gross Profit = Revenue – Cost of Goods Sold (COGS)

Revenue — all cash inflows from the sale of goods or services.
Cost of Goods Sold — direct costs related to the production or acquisition of goods:
  • Raw materials and supplies
  • Wages of production personnel
  • Depreciation of equipment
  • Transportation and warehousing costs (if directly related to production)
Importance for business:
  • Assessing core business profitability
    If gross profit is declining, it may indicate rising production costs or falling sales.
  • Financial planning
    Gross profit is the basis for calculating other key metrics, such as operating and net profit.
  • Benchmarking against competitors
    Gross profit analysis helps compare the efficiency of different companies within the same industry.
  • Insights into pricing effectiveness
    If gross profit is low, the company may be pricing too low or failing to control costs effectively.
Reasons for a decline in gross profit:
  • Increase in raw material and supply costs
  • Rising production expenses
  • Price reductions due to competition
  • Decrease in sales volume
  • Currency exchange rate fluctuations (for imports/exports)

Gross profit is an important metric, but it does not provide a complete picture of a company’s financial health, as it does not account for administrative and selling expenses, taxes, debt burden, or depreciation.

Annual Gross Profit CEL-SCI Corporation

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008
- - - - - - - - - - - - - 255 K 956 K - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
956 K 255 K 605 K

Gross Profit of other stocks in the Biotechnology industry

Issuer Gross Profit Price % 24h Market Cap Country
Clovis Oncology Clovis Oncology
CLVS
123 M - -7.23 % $ 13 M usaUSA
Concert Pharmaceuticals Concert Pharmaceuticals
CNCE
7.9 K - - $ 401 M usaUSA
Rezolute Rezolute
RZLT
-4.84 K $ 3.94 1.87 % $ 299 M usaUSA
BioLineRx Ltd. BioLineRx Ltd.
BLRX
950 K $ 2.52 1.17 % $ 6.21 B israelIsrael
BioMarin Pharmaceutical BioMarin Pharmaceutical
BMRN
1.34 B $ 61.35 0.06 % $ 11.8 B usaUSA
Benitec Biopharma Benitec Biopharma
BNTC
282 K $ 9.64 0.46 % $ 449 M usaUSA
Genocea Biosciences Genocea Biosciences
GNCA
1.36 K - -15.0 % $ 3.04 M usaUSA
Amryt Pharma plc Amryt Pharma plc
AMYT
116 M - - $ 621 M britainBritain
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
2.03 M $ 2.17 0.46 % $ 3.57 M israelIsrael
Catalyst Biosciences Catalyst Biosciences
CBIO
102 M $ 14.24 0.35 % $ 1.27 B usaUSA
C4 Therapeutics C4 Therapeutics
CCCC
33.2 M $ 3.03 0.3 % $ 251 M usaUSA
Codexis Codexis
CDXS
52.8 M $ 1.37 1.45 % $ 119 M usaUSA
Cerus Corporation Cerus Corporation
CERS
60.4 M $ 2.61 0.38 % $ 497 M usaUSA
AbbVie AbbVie
ABBV
12.1 B $ 265.12 0.09 % $ 469 B usaUSA
Coherus BioSciences Coherus BioSciences
CHRS
339 M $ 1.17 1.48 % $ 137 M usaUSA
Abeona Therapeutics Abeona Therapeutics
ABEO
925 K $ 5.43 2.65 % $ 288 M usaUSA
Celldex Therapeutics Celldex Therapeutics
CLDX
5.48 M $ 31.48 1.16 % $ 2.09 B usaUSA
CollPlant Biotechnologies Ltd. CollPlant Biotechnologies Ltd.
CLGN
1.54 M $ 4.12 1.98 % $ 50.3 M israelIsrael
Фармсинтез Фармсинтез
LIFE
160 M - - - russiaRussia
Cocrystal Pharma Cocrystal Pharma
COCP
7.22 M $ 1.15 1.67 % $ 13 M usaUSA
Collegium Pharmaceutical Collegium Pharmaceutical
COLL
128 M $ 22.64 0.85 % $ 717 M usaUSA
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
CORT
301 M $ 118.51 4.93 % $ 12.3 B usaUSA
Chimerix Chimerix
CMRX
212 K - - $ 756 M usaUSA
Corbus Pharmaceuticals Holdings Corbus Pharmaceuticals Holdings
CRBP
3.94 M $ 7.45 0.19 % $ 99.2 M usaUSA
Curis Curis
CRIS
9.5 M $ 0.88 0.85 % $ 11.6 M usaUSA
CorMedix CorMedix
CRMD
276 M $ 7.77 1.04 % $ 560 K usaUSA
Champions Oncology Champions Oncology
CSBR
12.8 M $ 4.95 0.38 % $ 68.5 M usaUSA
Arbutus Biopharma Corporation Arbutus Biopharma Corporation
ABUS
-40.6 M $ 4.88 0.62 % $ 935 M canadaCanada
Cue Biopharma Cue Biopharma
CUE
3.15 M $ 32.85 3.6 % $ 3.11 B usaUSA